search
IBRX
Trends
- 1Retail Traders Eye SLS, IBRX After Moderna's Nasdaq-100 Entry▼SLS, IBRX Stocks Draw Retail Chatter As MRNA Lands A Nasdaq-100 Spot – ‘It Will Be SLS Next’
Retail investors are buzzing about Sellas Life Sciences (SLS) and Immix Biopharma (IBRX) after Moderna's MRNA secured a spot in the Nasdaq-100 index. Some traders are speculating that a small-cap biotech like SLS could be the next index addition, fueling optimism around the two stocks on trading forums.
- 2ImmunityBio Shares Post Best Week In Over Seven Months▼IBRX Stock Logs Best Week In Over 7 Months: Retail Eyes Anktiva Boost From Trump’s Cancer Panel Pick
ImmunityBio stock (IBRX) recorded its strongest weekly performance in more than seven months, drawing attention from retail investors. Traders are speculating that Anktiva, the company's bladder cancer drug, could get a lift following Donald Trump's choice for his cancer panel, fueling optimism about regulatory and commercial support for the therapy.
- 3IBRX Falls While Retail Investors Call It a Bargain▼IBRX Stock Under Pressure: Retail Sees 'Ridiculously Cheap' Bargain As Founder Touts Sister Firm NantIQ's Aetna Work
ImmunityBio (IBRX) shares are under pressure, but retail investors are arguing the stock is 'ridiculously cheap' and view the dip as a buying opportunity. Adding to the conversation, founder Patrick Soon-Shiong is promoting work by his sister company NantIQ with insurer Aetna. Traders are divided between bearish price action and bullish conviction in the company's long-term prospects.
- 4SLS and IBRX climb as Moderna joins Nasdaq-100▼SLS, IBRX Stocks Climb Overnight: Retail Eyes Moderna’s Rally As MRNA Lands A Nasdaq-100 Spot
SLS and IBRX shares rose in overnight trading while retail investors turned their attention to Moderna after the biotech was added to the Nasdaq-100 index. Traders are watching whether Moderna's inclusion sparks a broader rally in biotech names, with retail chatter focused on momentum across MRNA and related small-cap stocks heading into the next session.
- 5IBRX Rises Overnight as Retail Traders Seek Global Expansion Clues●IBRX Stock Rises Overnight: Retail Traders Hunt For Global Expansion Clues Ahead Of Biotech Conference
Shares of ImmunityBio (IBRX) moved higher in overnight trading as retail traders looked for signs of the company's global expansion plans ahead of an upcoming biotech conference. Investors are watching for pipeline updates and international partnership announcements that could clarify the company's growth strategy and support the recent stock gains.
- 6Retail biotech favorites SLS, IBRX, VNDA, IOVA vs September slump▼Biotech Lagged The Broader Market In September — Did Retail Favorites SLS, IBRX, VNDA And IOVA Dodge XBI’s Slump?
Biotech stocks lagged the broader market in September, with the SPDR S&P Biotech ETF (XBI) falling while the wider market held up better. Attention is now on whether retail-favored names SELLAS Life Sciences (SLS), ImmunityBio (IBRX), Vanda Pharmaceuticals (VNDA) and Iovance Biotherapeutics (IOVA) managed to escape the sector's slump. Investors are weighing whether these popular small-cap biotechs diverged from the wider sector weakness.
- 7SLS Stock Rises Overnight as Retail Traders Pick Sellas as Most Bullish Play●SLS Stock Rises Overnight: Why Retail Traders Prefer Sellas Over IBRX, ONDS, PYPL As Most Bullish Pick
Sellas Life Sciences (SLS) shares climbed in overnight trading, with retail traders naming it a more bullish pick than Immunicom-linked peer IBRX, Ondas (ONDS) and PayPal (PYPL). Traders on social platforms compared the stocks, favoring SLS for its momentum and speculative upside despite its small-cap risk profile.
- 8Stock Futures Rise Ahead of Jobs Report Despite Higher Yields▼Dow, S&P 500, Nasdaq Futures Rise Despite Soaring Treasury Yields As Markets Eye Jobs Report: MU, NKE, IBRX, CEG Stocks In Focus
US stock index futures pointed higher despite a sharp rise in Treasury yields, with investors focused on the upcoming jobs report for signals on the economy and interest rate outlook. Micron, Nike, iBio-branded Ibrx and Constellation Energy shares were flagged as stocks to watch in the session ahead.